Pay in 4 interest-free payments of $7.21 Learn more
Ships within 48 hours · Estimated delivery Aug 24 - Aug 29
Most Adults need around 2.4 micrograms of vitamin B12 a day
REDEFINE-1: Phase 3 Pivotal Trial (NCT05064293) Study Title: "Efficacy and Safety of CagriSema in Adults With Overweight or Obesity (REDEFINE 1)" Status: Completed (Results Published 2024) Phase: Phase 3 Enrollment: 3,400+ participants Study Period: 2021-2024 Location: Global, 15+ countries Design: Randomized, double-blind, active-controlled Duration: 68 weeks Intervention: CagriSema (cagrilintide 2.4mg + semaglutide 2.4mg) vs
Gamulin et al., 2013
Match the vial to the timeline
US$ 20.59
US$ 29.19
US$ 25.93
US$ 25.84
US$ 22.85
US$ 20.04
US$ 22.02
